SPECTRUMK GMBH has floated a tender for Completion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 or 130C Paragraph 1 Sgb V for the Period from May 1St, 2024 to April 30Th, 2026. The project location is Germany and the tender is closing on 08 Apr 2024. The tender notice number is 173438-2024, while the TOT Ref Number is 99187033. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Germany

Summary : Completion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 or 130C Paragraph 1 Sgb V for the Period from May 1St, 2024 to April 30Th, 2026

Deadline : 08 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 99187033

Document Ref. No. : 173438-2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : SPECTRUMK GMBH
Town: Essen
NUTS-Code: DEA13
Postal Code: 45128
Phone: 000
Germany
Email :open-house@spectrumk.de

Tender Details

This announcement serves to conclude drug discount contracts in accordance with Sections 130a Paragraph 8 and 130c Paragraph 1 SGB. This does not involve the awarding of public contracts within the meaning of Directive 2014/24/EU or Sections 97 ff GWB. Any pharmaceutical company can be a contractual partnerin accordance with Section 4 Paragraph 18 AMG. According to the case law of the ECJ, such approval procedures are not necessarily subject to public procurement law, since no competition takes place due to the lack of a selection decision. The announcement serves as an invitation to conclude discount agreements with everyonee contractual partners equally applicable and non-dispositive conditions including the determination of the discount. The contract is concluded by signing the contract documents and submitting the required declarations, which can be requested from the named contact point.

Active ingredientf Ciclopirox, ATC code: G01AX12, dosage form: vaginal cream (VCR), vaginal suppositories (VSU), effective strength: 10 mg, pack size: N1 (without clinic packs)

This announcement serves to conclude drug discount contracts in accordance with Section 130a Paragraph 8 or 130c Paragraph 1 SGB V about the belowr active ingredient(s) mentioned in the title. This does not involve the awarding of public contracts within the meaning of Directive 2014/24/EU or Sections 97 ff GWB. Any pharmaceutical company can become a contractual partner in accordance with Section 4 Paragraph 18 AMG. According to the case law of the ECJ, such authorization is subject to approval...
Document Type: Contract Notice
Reference Number: 001
Contract Type: supplies
Authority Type: pub-undert
Doc Title: Conclusion of a non-exclusive. Discount contract according to Section 130a Paragraph 8 or 130c Paragraph 1 SGB V for the period from May 1st, 2024 to April 30th, 2026
Dispatch Date: 2024-03-20
Publish Date: 2024-03-22
Submission Date: 2024-04-08

Documents

 Tender Notice